Reported results
- Net sales of $234.6 million, up 7.1% from $219.0 million in the prior-year first quarter, despite one fewer week in the current quarter
- GAAP operating income of $24.9 million (10.6% operating margin), up 7.2% from $23.3 million (10.6% operating margin) in the first quarter of fiscal 2026
- GAAP diluted earnings per share of $0.40, up 21.2% from $0.33 in the first quarter of fiscal 2026
- GAAP net income of $19.4 million compared to $16.5 million in the first quarter of fiscal 2026
- Product backlog of $311.3 million at quarter-end, marking the sixth consecutive quarter with backlog exceeding $300 million
- Operating cash flow of $31.4 million compared to $26.1 million in the prior-year first quarter; period-end cash balance of $154.6 million
Guidance
- Fiscal 2028 targets: 7-10% revenue CAGR, 10-12% operating margin, and 17-20% ROIC
Notes
Fiscal 2027 Q1 includes 13 weeks of results versus 14 weeks in the prior-year Q1 due to fiscal 2027 being a 52-week year while fiscal 2026 was a 53-week year. Orders and backlog are non-GAAP operating measures. The release includes non-GAAP reconciliations for free cash flow and EBITDA.
Price and volatility reaction
The stock moved -1.2% on the print. No front-expiry chain was on file, so there is no straddle expected move. 30-day ATM implied volatility moved -22.2 vol points across the event (constant-maturity series — not the front-week crush).
| Measure | Value | Basis |
|---|---|---|
| Close before release | 19.36 | 2026-09-01 |
| Close after release | 19.13 | 2026-09-02 |
| Realised move | -1.2% | close to close |
| 30d ATM IV change | -22.2 vol pts | constant-maturity series, not the front expiry |
Source
The figures above come from the earnings release the company filed with the SEC on 2026-09-02 (8-K, Item 2.02). Read the original filing on sec.gov.